WHAT THEY ARE SAYING: LOWERING Rx PRICES & HOLDING BIG PHARMA ACCOUNTABLE TOP PRIORITY IN 2020
Editorial Boards, Lawmakers and More Reiterate Need for Market-Based Solutions… Read More
Editorial Boards, Lawmakers and More Reiterate Need for Market-Based Solutions… Read More
News from First Weeks of New Year Underscores Urgent Need for Action in… Read More
Drug Makers, Including Brand Name Giants Like Pfizer, Increase Prices on More… Read More
Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the… Read More
CMS Report Demonstrates Impact of Out-of-Control Launch Prices and Tactics… Read More
Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress… Read More
Revisions to Historic Trade Deal Remove Big Pharma Carveout Washington… Read More
Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times… Read More
Analysis of Multiple Sclerosis Drug Pricing Undercuts Drug Makers’ Bogus… Read More
Political Courage Needed to Deliver on Drug Prices By Lauren Aronson Real… Read More
Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers… Read More
Nine in Ten Surveyed Adults Believe Rx Prices “Much Higher” Or “Somewhat… Read More